source
- Merck's Welireg receives FDA nod for expanded use with Lenvima in kidney cancerMerck announced that its drug Welireg has received FDA approval for use together with Eisai's Lenvima in patients with advanced renal cell carcinoma. The clearance broadens the indication, allowin…
- Adicet Bio's off-the-shelf CAR-T therapy shows lupus remission in early Phase 1 trialAdicet Bio reported that its off-the-shelf CAR-T product prula-cel induced remission in more than half of lupus patients enrolled in a small Phase 1 study. One year after a single infusion, 12 of…